IRS 990 Nonprofit Profile
Readdi INC
The rapidly emerging antiviral drug development initiative (readdi) is a nonprofit biotechnology organization dedicated to preventing global catastrophes caused by viruses. it plays a clear, specific and central role in the widely accepted three-pronged pandemic preparedness approach involving diagnostics, therapeutics and vaccines. readdi develops therapeutics.
- Filing year
- 2024
- Total revenue
- $624K
- Total expenses
- $1.1M
- Program expenses
- $344K
- Administration
- $290K
- Fundraising
- $492K
- Program share of expenses
- 31%
- EIN
- 883812342
- Location
- Durham, NC
About CharitySense
CharitySense provides live, independent intelligence from the charitable infrastructure you fund — hospitals, schools, orphanages, and clinics anywhere in the world.
See live projects or read our insights on nonprofit accountability.
Financial data on this page is sourced from IRS Form 990 filings.